Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …

Background Hydroxychloroquine or chloroquine with or without azithromycin have been
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …

Importance Patients with specific cancers may be at higher risk than those without cancer for
coronavirus disease 2019 (COVID-19) and its severe outcomes. At present, limited data are …

Background Patients with cancer may be at high risk of adverse outcomes from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of …

To the Editor—To and colleagues reported the first documented case of an asymptomatic
reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after 4.5 …

Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS …

Published series on COVID-19 support the notion that patients with cancer are a particularly
vulnerable population. There is a confluence of risk factors between cancer and COVID-19 …

Less than a year since the start of the COVID-19 pandemic, ten vaccines against SARS-CoV-
2 have been approved for at least limited use, with over sixty others in clinical trials. This …

Abstract Coronavirus disease 2019 (COVID-19) is an illness resulting from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in late 2019. Patients with …